Revvity | PKI - Capital Social e Reservas





Capital Social e Reservas Alterar Data
Agilent USD 7.12B 214M 2026-03
Align Technology USD 4.15B 100.27M 2026-03
Bio Techne USD 2.09B 74.32M 2026-03
Bio-Rad Laboratories USD 6.85B 602.3M 2026-03
Bruker USD 2.46B 35.9M 2025-12
Celltrion KRW 434.82B 1.14B 2026-03
Charles River Laboratories USD 2.9B 265.94M 2026-03
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.32B 21M 2026-03
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Edwards Lifesciences USD 10.33B 10.1M 2026-03
Illumina USD 2.68B 47M 2026-03
Intuitive Surgical USD 18.17B 693.9M 2026-06
IQVIA Holdings USD 6.22B 282M 2026-03
Kangmei Pharma CNY 7.31B 84.82M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Laboratory Of America USD 8.73B 108.8M 2026-03
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Mesa Laboratories USD 186.69M 8.22M 2025-12
Mettler Toledo International USD -41.88M 18.25M 2026-03
Myriad Genetics USD 337.4M 30.6M 2026-03
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
OraSure Technologies USD 313.32M 27.5M 2026-03
Organigram Holdings CAD 371.81M 2.36M 2026-03
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pacific Biosciences Of California USD 2.37M 2.98M 2026-03
Pharma Mar EUR 249.67M 2.16M 2026-03
Qiagen NV USD 3.33B 446.45M 2026-03
Quest Diagnostics USD 7.52B 150M 2026-06
Quidel USD 1.85B 69.1M 2026-03
Repligen USD 2.11B 666K 2026-03
Revvity USD 7.25B 125.54M 2025-12
Sartorius EUR 2.82B 96.3M 2026-06
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Tilray USD 1.58B 39.08M 2025-09
Waters USD 2.56B 230.55M 2025-12
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03